BACKGROUND: The association between adiponectin and nonalcoholic fatty liver disease (NAFLD) has been studied before, but most of the studies are cross-sectional and cannot prove a causal link. OBJECTIVE: To prospectively investigate the relationship between serum adiponectin levels and the incidence of NAFLD in 3 years. SUBJECTS AND METHODS: A total of 1325 subjects aged 40 to 70 from the Chongming District of Shanghai, China, were included. All of them did not have fatty liver according to the liver ultrasound examination at entry; alcohol abuse and hepatitis were also excluded. Serum adiponectin levels and other indices were measured at baseline. After 3 years of follow-up, hepatic ultrasound examination was performed on each participant again to detect fatty liver. RESULTS: The serum adiponectin levels at entry were significantly lower in subjects who developed NAFLD compared with those who did not develop NAFLD after 3 years (1.75 ± 0.89 ug/mL vs 2.37 ± 1.01 ug/mL, P < 0.001). After multiple adjustments, the highest odds ratios for NAFLD were in the second adiponectin quartile, the adjusted ORs were 1.89 (95% confidence interval [CI] 1.25 to 2.86) compared with those in the highest quartile. Multivariate logistic regression analysis showing variables at entry independently associated with NAFLD after 3 years was adiponectin (P < 0.01), sex (P < 0.01), BMI (P < 0.001), insulin (P < 0.001), HOMA-IR (P < 0.01), GGT (P = 0.001), TG (P < 0.001), and WBC (P < 0.001). CONCLUSIONS: Lower serum adiponectin level is a predictor of NAFLD among middle-aged and elderly subjects.
BACKGROUND: The association between adiponectin and nonalcoholic fatty liver disease (NAFLD) has been studied before, but most of the studies are cross-sectional and cannot prove a causal link. OBJECTIVE: To prospectively investigate the relationship between serum adiponectin levels and the incidence of NAFLD in 3 years. SUBJECTS AND METHODS: A total of 1325 subjects aged 40 to 70 from the Chongming District of Shanghai, China, were included. All of them did not have fatty liver according to the liver ultrasound examination at entry; alcohol abuse and hepatitis were also excluded. Serum adiponectin levels and other indices were measured at baseline. After 3 years of follow-up, hepatic ultrasound examination was performed on each participant again to detect fatty liver. RESULTS: The serum adiponectin levels at entry were significantly lower in subjects who developed NAFLD compared with those who did not develop NAFLD after 3 years (1.75 ± 0.89 ug/mL vs 2.37 ± 1.01 ug/mL, P < 0.001). After multiple adjustments, the highest odds ratios for NAFLD were in the second adiponectin quartile, the adjusted ORs were 1.89 (95% confidence interval [CI] 1.25 to 2.86) compared with those in the highest quartile. Multivariate logistic regression analysis showing variables at entry independently associated with NAFLD after 3 years was adiponectin (P < 0.01), sex (P < 0.01), BMI (P < 0.001), insulin (P < 0.001), HOMA-IR (P < 0.01), GGT (P = 0.001), TG (P < 0.001), and WBC (P < 0.001). CONCLUSIONS: Lower serum adiponectin level is a predictor of NAFLD among middle-aged and elderly subjects.
Authors: K M Choi; O H Ryu; K W Lee; H Y Kim; J A Seo; S G Kim; N H Kim; D S Choi; S H Baik Journal: Diabetes Res Clin Pract Date: 2006-07-26 Impact factor: 5.602
Authors: Douglas R LaBrecque; Zaigham Abbas; Frank Anania; Peter Ferenci; Aamir G Khan; Khean-Lee Goh; Saeed S Hamid; Vasily Isakov; Maribel Lizarzabal; Manuel M Peñaranda; Juan F R Ramos; Shiv Sarin; Davor Stimac; Alan B R Thomson; Muhammed Umar; Justus Krabshuis; Anton LeMair Journal: J Clin Gastroenterol Date: 2014-07 Impact factor: 3.062
Authors: Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George Journal: Hepatology Date: 2004-07 Impact factor: 17.425
Authors: Farah D R Al-Baiaty; Aziana Ismail; Zarina Abdul Latiff; Khairul Najmi Muhammad Nawawi; Raja Affendi Raja Ali; Norfilza Mohd Mokhtar Journal: Front Pediatr Date: 2021-07-08 Impact factor: 3.418
Authors: Emir Tas; Shasha Bai; Xiawei Ou; Kelly Mercer; Haixia Lin; Kori Mansfield; Robert Buchmann; Eva C Diaz; Jon Oden; Elisabet Børsheim; Sean H Adams; Jonathan Dranoff Journal: Front Endocrinol (Lausanne) Date: 2020-09-17 Impact factor: 5.555
Authors: Rasha R El-Kady; Amani K Ali; Lamia M El Wakeel; Nagwa A Sabri; May A Shawki Journal: Ther Adv Chronic Dis Date: 2022-02-23 Impact factor: 5.091
Authors: Valerio Rosato; Mario Masarone; Marcello Dallio; Alessandro Federico; Andrea Aglitti; Marcello Persico Journal: Int J Environ Res Public Health Date: 2019-09-14 Impact factor: 3.390